I agree completely. I was so thankful for the dividend and
I agree completely. I was so thankful for the dividend and it showed that this is a real company with a good future. I also believed strongly in Adam Carter and the PR's, and that is why I reinvested the dividend once etrade finally put it in my account. Right after, the halt came and the value has been wiped out. I am shocked that given the earnings of the company, the value of the shares has literally been wiped out after the halt. I hope somehow Adam Carter or some new company somehow makes this right for us shareholders.
The only possibility I see is that we will get bought out or have our shares exchanged for shares in a new company as a result of the merger they PR'd. Beyond that, I don't know if there is a way we will ever return to .01 or anything else for that matter. We aren't getting there on the greys, I'm sure.
Meanwhile this is a 99% loss sitting in my account which obviously is terrible, so I hope that merger they PR'd happens and us shareholders are a part of it, sooner rather than later.
Calissio Resources Group, Inc. (CRGP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...
Continue Reading
Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...
Continue Reading
Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...
Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...
Continue Reading
Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...
Continue Reading
